Skip to main content
OpenTrials
Completed

NCT Number: NCT05756335

The Brain Metabolism of Unpredictable Signals

The investigators will be studying brain glucose and oxygen metabolism using hybrid PET/fMRI imaging to better understand how decoupling between brain glucose and oxygen metabolism relates to the processing of unpredictable sensory signals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

21 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Athinoula A. Martinos Center for Biomedical Imaging

Charlestown, Massachusetts, 02129, United States

About this study

The proposed research consists of one experiment, combining positron emission tomography (PET) and magnetic resonance imaging (MRI) techniques to simultaneously estimate the cerebral metabolic rates of glucose (CMRglc) and oxygen (CMRO2), and their ratio (oxygen:glucose index; OGI). These outcome measures will be collected in the context of a behavioral intervention presenting subjects with predictable and unpredictable stimuli, and attended and unattended stimuli. Functional PET uses a slow infusion of 2-[18F]-fluro-deoxyglucose (FDG) to estimate regional CMRglc, measuring relative changes in radiotracer uptake between blocks of task and rest. Dual-calibrated fMRI uses a sequence of hyperoxic (increased O2) and hypercapnic (increased CO2) challenges, along with a specialized sequence of MRI scans (estimating cerebral blood flow and blood-oxygen level-dependent signal) to estimate absolute CMRO2.

All subjects will be scanned, and each will complete the same behavioral intervention. First, the investigators will aim to assess the reliability of this hybrid imaging technique by having subjects complete two identical scan sessions. Second, the investigators will deliver a behavioral intervention to test the relationship between stimuli predictability, CMRglc, CMRO2, and OGI.

This experimental design is capable of producing effects observable in single subjects, and prior studies using fPET and dual-calibrated fMRI have produced effect sizes that our sample size is more than adequate to detect.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 21-35.
  • No contraindications to MRI or PET scanning.
  • Right-handed.
  • Fluent to speak, read, and understand English.

Exclusion criteria

  • Adults unable to consent
  • Contraindications to fMRI scanning and PET scanning (including the presence of a cardiac pacemaker or pacemaker wires, metallic particles in the body, vascular clips in the head or previous neurosurgery, prosthetic heart valves, claustrophobia)
  • Inability to lie motionless in the scanner
  • Pregnancy, seeking or suspecting pregnancy, or breastfeeding
  • History of major head trauma
  • Intracranial lesion
  • Cardiovascular disorders, including heart disorders or high blood pressure [>155/95]
  • Breathing problems such as severe asthma, emphysema, or pulmonary disease
  • Bleeding disorder, or use of anticoagulants
  • Bladder obstruction, urinary problems, or history of impaired elimination
  • Known kidney or liver problems
  • Past severe COVID-19 infection
  • Intestinal blockage
  • Raynaud syndrome
  • Anemia
  • Peripheral nerve injury
  • Diabetes
  • Glaucoma
  • Current or recent use of medications (neurological or psychiatric) affecting brain function
  • Current or past history of major medical, neurological, or psychiatric condition
  • Current or past history of chronic pain (assessed at the discretion of PI)
  • Current smoker
  • Body mass index above 35
  • Research-related radiation exposure exceeds current Radiology Department guidelines
  • Lack of current health insurance coverage
  • Employed under the direct supervision of the investigators conducting the research
  • Unwilling or unable to cooperate with breathing maneuvers required during the gas challenge
  • Respiratory or cardiac limitations to breathing at 20 L/min

Treatment and study plan

(Un)predictable and (un)attended stimuli

Behavioral

Subjects will complete four task conditions in each scan session: (1) Visual Unpredictable, (2) Visual Predictable, (3) Auditory Unpredictable, and (4) Auditory Predictable. In visual and auditory conditions subjects attend to visual or auditory stimuli and ignore the other domain, pressing a button when they detect an infrequently occurring stimulus inversion in the target domain. In unpredictable and predictable conditions, the attended domain either presents random (unpredictable) stimuli, or the same face or word stimuli repeated (predictable).

Primary outcomes

  1. Brain positron emission tomography (PET) imaging signals

    Time frame: after PET image analysis and with study completion, an average of 1 year

    Changes in glucose metabolism will be quantified from brain PET images

  2. Functional magnetic resonance imaging (fMRI) signals

    Time frame: after fMRI image analysis and with study completion, an average of 1 year

    Changes in oxygen metabolism will be quantified from dual-calibrated fMRI

  3. Oxygen-glucose index

    Time frame: after PET/fMRI image analysis and with study completion, an average of 1 year

    Ratio of cerebral metabolic rates of glucose and oxygen from PET and fMRI signals

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Official study title

Quantifying the Brain Metabolism Underlying Task-Based BOLD Imaging

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Mar 6, 2023
Registry last updated
Jul 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.